SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-068835
Filing Date
2021-05-18
Accepted
2021-05-18 16:07:59
Documents
1
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2116776-4_4.html 4  
1 OWNERSHIP DOCUMENT tm2116776-4_4.xml 4 4077
  Complete submission text file 0001104659-21-068835.txt   5488
Mailing Address 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address
Kelly Leanne M. (Reporting) CIK: 0001398278 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 21936016

Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations